Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06666673 · ClinicalTrials.gov registry record · Early Phase 1

Effect of Neural Constraints on Movement in Stroke

A Early Phase 1 study of Stroke, sponsored by Northwestern University.

Recruiting
Registry status
Early Phase 1
Development phase
64
Enrollment target
1
Study location

NCT06666673 is a Early Phase 1 study of Stroke that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 64 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06666673, a Early Phase 1 study of Stroke, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
Early Phase 1
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

This study investigates the effects of Tizanidine on the voluntary movement controls of the arms of participants who have had a stroke and have not had a stroke by measuring medication-induced changes in upper extremity kinematics, pupillometry, and brain activity. Tizanidine is approved by the U.S. Food and Drug Administration. Understanding how different areas of the brain are involved in movement impairments may help rehabilitation efforts and assist in restoring healthy movement in individuals who have had a stroke.

Conditions Studied

Stroke

Interventions

  • DRUG Placebo
  • DRUG Tizanidine

Study Locations (1)

Illinois

  • Northwestern University, Dept. of PTHMS 645 N Michigan Ave, Suite 1100 - Chicago

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2024-08-23
Est. Completion 2029-07-31
Phase Early Phase 1

Sponsor

Northwestern University

1,209 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06666673

The ClinicalTrials.gov registry entry for NCT06666673 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (99% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06666673 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06666673 about?

NCT06666673 is a clinical study titled "Effect of Neural Constraints on Movement in Stroke". This study investigates the effects of Tizanidine on the voluntary movement controls of the arms of participants who have had a stroke and have not had a stroke by measuring medication-induced changes in upper extremity kinematics, pupillometry, and brain activity. Tizanidine is approved by the U.S....

What is the current status of trial NCT06666673?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2024-08-23. Estimated completion is 2029-07-31.

What conditions does trial NCT06666673 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06666673?

The interventions under investigation include: Placebo (DRUG), Tizanidine (DRUG).

Who is sponsoring clinical trial NCT06666673?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06666673 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.